图书馆订阅: Guest
医药载体系统评论综述

每年出版 6 

ISSN 打印: 0743-4863

ISSN 在线: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Oral Delivery of Proteins: Progress and Prognostication

卷 19, 册 2, 2002, 35 pages
DOI: 10.1615/CritRevTherDrugCarrierSyst.v19.i2.20
Get accessGet access

摘要

The delivery of proteins has gained momentum with the development of biotechnology sector that provided large-scale availability of therapeutic proteins. The availability is mostly due to the advances in recombinant DNA technology. The low oral bioavailability, however, continues to be a problem for several proteins because of their large molecular size, low permeation through biological membranes, and susceptibility to molecular changes in both biological and physical environments. The demand for effective delivery of proteins by the oral route has brought a tremendous thrust in recent years both in the scope and complexity of drug delivery technology. The important therapeutic proteins and peptides being explored for oral delivery include insulin, calcitonin, interferons, human growth hormone, glucagons, gonadotropin-releasing hormones, enkephalins, vaccines, enzymes, hormone analogs, and enzyme inhibitors. This article reviews the progress in oral delivery of these proteins, provides comments on the strategies to improve their oral bioavailability, and highlights their current market trends.

对本文的引用
  1. Pawar Rajendra, Ben-Ari Alon, Domb Abraham J, Protein and peptide parenteral controlled delivery, Expert Opinion on Biological Therapy, 4, 8, 2004. Crossref

  2. Chow Albert H.L., Tong Henry H.Y., Zheng Ying, Stability Assessment and Formulation Characterization, in Pharmaceutical Sciences Encyclopedia, 2010. Crossref

  3. Brown Larry R, Commercial challenges of protein drug delivery, Expert Opinion on Drug Delivery, 2, 1, 2005. Crossref

  4. Shah Rakhi B., Khan Mansoor A., Protection of salmon calcitonin breakdown with serine proteases by various ovomucoid species for oral drug delivery, Journal of Pharmaceutical Sciences, 93, 2, 2004. Crossref

  5. Lee S., Lee J., Lee D. Y., Kim S. K., Lee Y., Byun Y., A new drug carrier, N?-deoxycholyl-l-lysyl-methylester, for enhancing insulin absorption in the intestine, Diabetologia, 48, 3, 2005. Crossref

  6. Hou Jianhua, Yan Ruixiang, Ding Dongfeng, Yang Liquan, Wang Cuiyan, Wu Zhiqiang, Yu Xiaoju, Li Weidong, Li Minggang, Oral administration of a fusion protein containing eight GLP-1 analogues produced in Escherichia coli BL21(DE3) in streptozotocin-induced diabetic rats, Biotechnology Letters, 29, 10, 2007. Crossref

  7. Park Jin Woo, Kim Sang Kyoon, Al-Hilal Taslim Ahmed, Jeon Ok Cheol, Moon Hyun Tae, Byun Youngro, Strategies for oral delivery of macromolecule drugs, Biotechnology and Bioprocess Engineering, 15, 1, 2010. Crossref

  8. Gomez-Orellana Isabel, Strategies to improve oral drug bioavailability, Expert Opinion on Drug Delivery, 2, 3, 2005. Crossref

  9. Shah Rakhi B., Khan Mansoor A., Regional permeability of salmon calcitonin in isolated rat gastrointestinal tracts: Transport mechanism using Caco-2 cell monolayer, The AAPS Journal, 6, 4, 2004. Crossref

  10. Hermansen Kjeld, Waiting to inhale: Noninjectable insulin, are we there yet?, Current Diabetes Reports, 4, 5, 2004. Crossref

  11. Föger F., Kopf A., Loretz B., Albrecht K., Bernkop-Schnürch A., Correlation of in vitro and in vivo models for the oral absorption of peptide drugs, Amino Acids, 35, 1, 2008. Crossref

  12. Takada Kanji, Oral Delivery of Hematopoietic Factors, American Journal of Drug Delivery, 4, 2, 2006. Crossref

  13. Cheng Mao-Bo, Wang Jian-Cheng, Li Yu-Hua, Liu Xiao-Yan, Zhang Xuan, Chen Da-Wei, Zhou Shu-Feng, Zhang Qiang, Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme, Journal of Controlled Release, 129, 1, 2008. Crossref

  14. Park Yoon-Jeong, Liang Jun-Feng, Song Hui, Li Yong Tao, Naik Sarita, Yang Victor C, ATTEMPTS: a heparin/protamine-based triggered release system for the delivery of enzyme drugs without associated side-effects, Advanced Drug Delivery Reviews, 55, 2, 2003. Crossref

  15. Salamat-Miller Nazila, Johnston Thomas P., Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium, International Journal of Pharmaceutics, 294, 1-2, 2005. Crossref

  16. Maher Sam, Leonard Thomas W., Jacobsen Jette, Brayden David J., Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic, Advanced Drug Delivery Reviews, 61, 15, 2009. Crossref

  17. Khafagy El-Sayed, Morishita Mariko, Onuki Yoshinori, Takayama Kozo, Current challenges in non-invasive insulin delivery systems: A comparative review, Advanced Drug Delivery Reviews, 59, 15, 2007. Crossref

  18. Bernkop-Schnürch Andreas, Krauland Alexander H, Leitner Verena M, Palmberger Thomas, Thiomers: potential excipients for non-invasive peptide delivery systems, European Journal of Pharmaceutics and Biopharmaceutics, 58, 2, 2004. Crossref

  19. Guggi Davide, Krauland Alexander H, Bernkop-Schnürch Andreas, Systemic peptide delivery via the stomach: in vivo evaluation of an oral dosage form for salmon calcitonin, Journal of Controlled Release, 92, 1-2, 2003. Crossref

  20. Shah Rakhi B., Nutan Mohammad, Khan Mansoor A., An Enteric Dual‐Controlled Gastrointestinal Therapeutic System of Salmon Calcitonin‐I: Preparation, Characterization, and Preclinical Bioavailability in Rats, Clinical Research and Regulatory Affairs, 21, 1, 2004. Crossref

  21. Liu Puchun, Dinh Steven, Oral Delivery of Protein/Peptide Therapeutics, in Oral Bioavailability, 2011. Crossref

  22. Kier Larry D., Petrick Jay S., Safety assessment considerations for food and feed derived from plants with genetic modifications that modulate endogenous gene expression and pathways, Food and Chemical Toxicology, 46, 8, 2008. Crossref

  23. Takagi Hidenori, Hiroi Takachika, Hirose Sakiko, Yang Lijun, Takaiwa Fumio, Rice seed ER-derived protein body as an efficient delivery vehicle for oral tolerogenic peptides, Peptides, 31, 8, 2010. Crossref

  24. Maroni Alessandra, Zema Lucia, Del Curto Maria Dorly, Foppoli Anastasia, Gazzaniga Andrea, Oral colon delivery of insulin with the aid of functional adjuvants, Advanced Drug Delivery Reviews, 64, 6, 2012. Crossref

  25. Saboktakin Mohammad Reza, Tabatabaie Roya M., Maharramov Abel, Ramazanov Mohammad Ali, Development and in vitro evaluation of thiolated chitosan—Poly(methacrylic acid) nanoparticles as a local mucoadhesive delivery system, International Journal of Biological Macromolecules, 48, 3, 2011. Crossref

  26. Morishita Mariko, Peppas Nicholas A., Is the oral route possible for peptide and protein drug delivery?, Drug Discovery Today, 11, 19-20, 2006. Crossref

  27. Bernkop-Schnürch Andreas, Hornof Margit, Guggi Davide, Thiolated chitosans, European Journal of Pharmaceutics and Biopharmaceutics, 57, 1, 2004. Crossref

  28. Bernkop-Schnürch Andreas, Egger Claudia, Elhassan Imam M., Krauland Alexander H., Preparation and in vitro characterization of poly(acrylic acid)–cysteine microparticles, Journal of Controlled Release, 93, 1, 2003. Crossref

  29. Niu Mengmeng, Lu Yi, Hovgaard Lars, Guan Peipei, Tan Yanan, Lian Ruyue, Qi Jianping, Wu Wei, Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: The effect of cholate type, particle size and administered dose, European Journal of Pharmaceutics and Biopharmaceutics, 81, 2, 2012. Crossref

  30. Santos Sara, Torcato Inês, Castanho Miguel A. R. B., Biomedical applications of dipeptides and tripeptides, Biopolymers, 98, 4, 2012. Crossref

  31. Chunfeng Guan, Xiaozhou Li, Gang Wang, Jing Ji, Chao Jin, Josine Tchouopou Lontchi, Expression of Cholera Toxin B–Lumbrokinase Fusion Protein in Pichia pastoris—The Use of Transmucosal Carriers in the Delivery of Therapeutic Proteins to Protect Rats Against Thrombosis, Applied Biochemistry and Biotechnology, 169, 2, 2013. Crossref

  32. Khafagy El-Sayed, Kamei Noriyasu, Takeda-Morishita Mariko, Cell-penetrating Peptide-biodrug Strategy for Oral and Nasal Delivery: Review of Recent Findings, Journal of Experimental & Clinical Medicine, 4, 4, 2012. Crossref

  33. Zhang Yaofang, Wang Weijing, Wei Yiming, Ma Baicheng, Qiao Kunyan, Ma Zhihua, Li Chong, Zhu Jian-Hong, Li Minggang, Construction of a Functional-Complementary Dual Insulinotropic Peptide rolGG and Its Therapeutic Effect on Type 2 Diabetes, International Journal of Peptide Research and Therapeutics, 18, 4, 2012. Crossref

  34. Zhu Zhaolu, Zhai Yinglei, Zhang Ning, Leng Donglei, Ding Pingtian, The development of polycarbophil as a bioadhesive material in pharmacy, Asian Journal of Pharmaceutical Sciences, 8, 4, 2013. Crossref

  35. Hammond Bruce, Kough John, Herouet-Guicheney Corinne, Jez Joseph M., Toxicological evaluation of proteins introduced into food crops, Critical Reviews in Toxicology, 43, sup2, 2013. Crossref

  36. Zhang Yaofang, Wei Yiming, Ma Baicheng, Qiao Kunyan, Ma Zhihua, Li Chong, Ma Chao, Ji Yanli, Dong Zhen, Hao Junfeng, Tu Peipei, Zhu Jian-Hong, Li Minggang, Expression of rolGLP-HV in E. coli and its Dual-Function for the Treatment of Diabetes and Thrombosis, International Journal of Peptide Research and Therapeutics, 19, 3, 2013. Crossref

  37. Muheem Abdul, Shakeel Faiyaz, Jahangir Mohammad Asadullah, Anwar Mohammed, Mallick Neha, Jain Gaurav Kumar, Warsi Musarrat Husain, Ahmad Farhan Jalees, A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives, Saudi Pharmaceutical Journal, 24, 4, 2016. Crossref

  38. Sonia Thundiparambil Azeez, Sharma Chandra P., Summary and future perspectives for oral insulin delivery, in Oral Delivery of Insulin, 2014. Crossref

  39. Müller Christiane, Bernkop-Schnürch Andreas, Thiomers, in Mucoadhesive Materials and Drug Delivery Systems, 2014. Crossref

  40. Ibie C., Knott R., Thompson C.J., In-vitro evaluation of the effect of polymer structure on uptake of novel polymer-insulin polyelectrolyte complexes by human epithelial cells, International Journal of Pharmaceutics, 479, 1, 2015. Crossref

  41. Ansari Mohammad Javed, Anwer Md. Khalid, Jamil Shahid, Al-Shdefat Ramadan, Ali Bahaa E., Ahmad Mohammad Muqtader, Ansari Mohammad Nazam, Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats, Drug Delivery, 2015. Crossref

  42. Ansari M.J., Oral Delivery of Insulin for Treatment of Diabetes: Classical Challenges and Current Opportunities, Journal of Medical Sciences, 15, 5, 2015. Crossref

  43. Kikuchi Kyoko, Sugiura Mika, Kimura Tadashi, High Proteolytic Resistance of Spider-Derived Inhibitor Cystine Knots, International Journal of Peptides, 2015, 2015. Crossref

  44. Singh Brahma N., Drug Delivery: Oral Route, in Encyclopedia of Biomedical Polymers and Polymeric Biomaterials, 2015. Crossref

  45. Huck Christian W., Pezzei Verena, Schmitz Thierry, Bonn Günther K., Bernkop-Schnürch Andreas, Oral peptide delivery: Are there remarkable effects on drugs through sulfhydryl conjugation?, Journal of Drug Targeting, 14, 3, 2006. Crossref

  46. Onishi Hiraku, Tokuyasu Ayako, Preparation and Evaluation of Enteric-Coated Chitosan Derivative-Based Microparticles Loaded with Salmon Calcitonin as an Oral Delivery System, International Journal of Molecular Sciences, 17, 9, 2016. Crossref

  47. Niu Zhigao, Conejos-Sánchez Inmaculada, Griffin Brendan T., O’Driscoll Caitriona M., Alonso María J., Lipid-based nanocarriers for oral peptide delivery, Advanced Drug Delivery Reviews, 106, 2016. Crossref

  48. Maculotti Katia, Tira Enrica M., Sonaggere Miriam, Perugini Paola, Conti Bice, Modena Tiziana, Pavanetto Franca, In vitroevaluation of chondroitin sulphate-chitosan microspheres as carrier for the delivery of proteins, Journal of Microencapsulation, 26, 6, 2009. Crossref

  49. Papineni Sabitha, Golden Rachel M., Thomas Johnson, The aryloxyalkanoate dioxygenase-12 (AAD-12) protein is not acutely toxic in mice, Food and Chemical Toxicology, 110, 2017. Crossref

  50. Cui Yi, Shan Wei, Liu Min, Wu Lei, Huang Yuan, A strategy for developing effective orally-delivered nanoparticles through modulation of the surface “hydrophilicity/hydrophobicity balance”, Journal of Materials Chemistry B, 5, 6, 2017. Crossref

  51. Ghosh Debadyuti, Peng Xiujuan, Leal Jasmim, Mohanty Rashmi P., Peptides as drug delivery vehicles across biological barriers, Journal of Pharmaceutical Investigation, 48, 1, 2018. Crossref

  52. Akhtar Fahad, Wan Xinyu, Wu Gang, Kesse Samuel, Wang Shaoda, He Shuying, Low-Molecular-Weight Heparins: Reduced Size Particulate Systems for Improved Therapeutic Outcomes, Molecules, 23, 7, 2018. Crossref

  53. Jog Rajan, Burgess Diane J., Nanoamorphous drug products – Design and development, International Journal of Pharmaceutics, 553, 1-2, 2018. Crossref

  54. Goldberg Michael, Gomez-Orellana Isabel, Challenges for the oral delivery of macromolecules, Nature Reviews Drug Discovery, 2, 4, 2003. Crossref

  55. Levin Galit, Gershonowitz Amikam, Sacks Hagit, Stern Meir, Sherman Amir, Rudaev Sergey, Zivin Inna, Phillip Moshe, Transdermal Delivery of Human Growth Hormone Through RF-Microchannels, Pharmaceutical Research, 22, 4, 2005. Crossref

  56. Özyazıcı Mine, Gökçe Evren Homan, Yurdasiper Aysu, Nanosized Drug Delivery for Enhancement of Oral Bioavailability, in Patenting Nanomedicines, 2012. Crossref

  57. Wang Kai, Su Yu, Liang Yuting, Song Yanhui, Wang Liping, Oral DhHP-6 for the Treatment of Type 2 Diabetes Mellitus, International Journal of Molecular Sciences, 20, 6, 2019. Crossref

  58. Zhou Xia, Wu Hongwei, Long Ruimin, Wang Shibin, Huang Haiwang, Xia Yanhua, Wang Pei, Lei Yifeng, Cai Yuanyuan, Cai Duanhua, Liu Yuangang, Oral delivery of insulin with intelligent glucose-responsive switch for blood glucose regulation, Journal of Nanobiotechnology, 18, 1, 2020. Crossref

  59. Cánepa Camila, Imperiale Julieta C., Berini Carolina A., Lewicki Marianela, Sosnik Alejandro, Biglione Mirna M., Development of a Drug Delivery System Based on Chitosan Nanoparticles for Oral Administration of Interferon-α, Biomacromolecules, 18, 10, 2017. Crossref

  60. Herrero Edgar P, Alonso Maria Jose, Csaba Noemi, Polymer-based oral peptide nanomedicines, Therapeutic Delivery, 3, 5, 2012. Crossref

  61. Lee Beom-Jin, Amin Hardik Hastibhai, Kang Taehee, Patient friendly strategy via chemical modification of proteins and peptides in oral delivery, in Advances and Challenges in Oral Delivery of Macromolecules, 2016. Crossref

  62. Deutel Britta, Greindl Melanie, Thaurer Michael, Bernkop-Schnürch Andreas, Novel Insulin Thiomer Nanoparticles: In Vivo Evaluation of an Oral Drug Delivery System, Biomacromolecules, 9, 1, 2008. Crossref

  63. Fazen Christopher H., Valentin Debbie, Fairchild Timothy J., Doyle Robert P., Oral Delivery of the Appetite Suppressing Peptide hPYY(3–36) through the Vitamin B12 Uptake Pathway, Journal of Medicinal Chemistry, 54, 24, 2011. Crossref

  64. Zhang Wenping, Wang Jian, Zhang Chen, Fang Qiang, Shu Jianhong, Li Si, Jin Jia, Wang Dan, Nie Zuoming, Lv Zhengbing, Zhang Yaozhou, Synergetic Protein Factors That Improve rhGM-CSF Absorption via an Oral Route Exist in Silkworm Pupae, Molecular Pharmaceutics, 12, 5, 2015. Crossref

  65. Schmitz T., Huck C. W., Bernkop-Schnürch A., Characterisation of the thiol–disulphide chemistry of desmopressin by LC, μ-LC, LC-ESI-MS and Maldi-Tof, Amino Acids, 30, 1, 2006. Crossref

  66. Gupta Vivek, Hwang Byeong Hee, Doshi Nishit, Mitragotri Samir, A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine, Journal of Controlled Release, 172, 2, 2013. Crossref

  67. Stagnoli Soledad, Sosa Alderete Lucas, Luna M. Alejandra, Agostini Elizabeth, Falcone R. Dario, Niebylski Ana M., Correa N. Mariano, Catanionic nanocarriers as a potential vehicle for insulin delivery, Colloids and Surfaces B: Biointerfaces, 188, 2020. Crossref

Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain